{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T02:26:26Z","timestamp":1777170386284,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Funds of China","doi-asserted-by":"crossref","award":["81271328"],"award-info":[{"award-number":["81271328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0610-y","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T09:13:37Z","timestamp":1465809217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Anti-inflammatory effect of cholera toxin B subunit in experimental stroke"],"prefix":"10.1186","volume":"13","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilong","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejiao","family":"Men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"610_CR1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1474-4422(11)70066-7","volume":"10","author":"R Macrez","year":"2011","unstructured":"Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10:471\u201380.","journal-title":"Lancet Neurol"},{"key":"610_CR2","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s10753-015-0211-4","volume":"38","author":"YS Wang","year":"2015","unstructured":"Wang YS, Li YX, Zhao P, Wang HB, Zhou R, Hao YJ, Wang J, Wang SJ, Du J, Ma L, et al. Anti-inflammation effects of oxysophoridine on cerebral ischemia-reperfusion injury in mice. Inflammation. 2015;38:2259\u201368.","journal-title":"Inflammation"},{"key":"610_CR3","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1111\/bph.13270","volume":"172","author":"J Zhao","year":"2015","unstructured":"Zhao J, Zhang X, Dong L, Wen Y, Zheng X, Zhang C, Chen R, Zhang Y, Li Y, He T, et al. Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia. Br J Pharmacol. 2015;172:5009\u201323.","journal-title":"Br J Pharmacol"},{"key":"610_CR4","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","volume":"40","author":"H Ehrenreich","year":"2009","unstructured":"Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40:e647\u201356.","journal-title":"Stroke"},{"key":"610_CR5","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/STROKEAHA.113.001531","volume":"44","author":"EB Ringelstein","year":"2013","unstructured":"Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, Saver J, Laage R, Schneider A, Rathgeb F, et al. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for ischemic stroke trial. Stroke. 2013;44:2681\u20137.","journal-title":"Stroke"},{"key":"610_CR6","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1073\/pnas.91.23.10795","volume":"91","author":"JB Sun","year":"1994","unstructured":"Sun JB, Holmgren J, Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci U S A. 1994;91:10795\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"610_CR7","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1073\/pnas.93.14.7196","volume":"93","author":"JB Sun","year":"1996","unstructured":"Sun JB, Rask C, Olsson T, Holmgren J, Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci U S A. 1996;93:7196\u2013201.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"610_CR8","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1073\/pnas.94.9.4610","volume":"94","author":"I Bergerot","year":"1997","unstructured":"Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Lindblad M, Mayer A, Czerkinsky C, Holmgren J, Thivolet C. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci U S A. 1997;94:4610\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"610_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2337\/diab.47.2.186","volume":"47","author":"DO Sobel","year":"1998","unstructured":"Sobel DO, Yankelevich B, Goyal D, Nelson D, Mazumder A. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse. Diabetes. 1998;47:186\u201391.","journal-title":"Diabetes"},{"key":"610_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.jcbfm.9600004","volume":"25","author":"W Zhang","year":"2005","unstructured":"Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab. 2005;25:30\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"key":"610_CR11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/intimm\/12.10.1449","volume":"12","author":"JB Sun","year":"2000","unstructured":"Sun JB, Xiao BG, Lindblad M, Li BL, Link H, Czerkinsky C, Holmgren J. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression. Int Immunol. 2000;12:1449\u201357.","journal-title":"Int Immunol"},{"key":"610_CR12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.neuroscience.2008.07.027","volume":"158","author":"KJ Becker","year":"2009","unstructured":"Becker KJ. Sensitization and tolerization to brain antigens in stroke. Neuroscience. 2009;158:1090\u20137.","journal-title":"Neuroscience"},{"key":"610_CR13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/brain\/awr008","volume":"134","author":"A Liesz","year":"2011","unstructured":"Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S, Sun L, Bruder D, Stegemann S, Cerwenka A, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134:704\u201320.","journal-title":"Brain"},{"key":"610_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2015.02.002","volume":"291","author":"QJ Shi","year":"2015","unstructured":"Shi QJ, Wang H, Liu ZX, Fang SH, Song XM, Lu YB, Zhang WP, Sa XY, Ying HZ, Wei EQ. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats. Neuroscience. 2015;291:53\u201369.","journal-title":"Neuroscience"},{"key":"610_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"EZ Longa","year":"1989","unstructured":"Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84\u201391.","journal-title":"Stroke"},{"key":"610_CR16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/01.STR.29.4.850","volume":"29","author":"T Tatlisumak","year":"1998","unstructured":"Tatlisumak T, Carano RA, Takano K, Opgenorth TJ, Sotak CH, Fisher M. A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke. 1998;29:850\u20137. discussion 857-858.","journal-title":"Stroke"},{"key":"610_CR17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1742-2094-9-147","volume":"9","author":"M Nikodemova","year":"2012","unstructured":"Nikodemova M, Watters JJ. Efficient isolation of live microglia with preserved phenotypes from adult mouse brain. J Neuroinflammation. 2012;9:147.","journal-title":"J Neuroinflammation"},{"key":"610_CR18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796\u2013808.","journal-title":"Nat Med"},{"key":"610_CR19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/STROKEAHA.113.003657","volume":"45","author":"M Marnane","year":"2014","unstructured":"Marnane M, Prendeville S, McDonnell C, Noone I, Barry M, Crowe M, Mulligan N, Kelly PJ. Plaque inflammation and unstable morphology are associated with early stroke recurrence in symptomatic carotid stenosis. Stroke. 2014;45:801\u20136.","journal-title":"Stroke"},{"key":"610_CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jamaneurol.2013.5026","volume":"71","author":"G Courties","year":"2014","unstructured":"Courties G, Moskowitz MA, Nahrendorf M. The innate immune system after ischemic injury: lessons to be learned from the heart and brain. JAMA Neurol. 2014;71:233\u20136.","journal-title":"JAMA Neurol"},{"key":"610_CR21","doi-asserted-by":"crossref","unstructured":"Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology. 2001, 57:1428-1434.","DOI":"10.1212\/WNL.57.8.1428"},{"key":"610_CR22","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/STROKEAHA.110.582601","volume":"41","author":"SC Fagan","year":"2010","unstructured":"Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, Hall CE, Switzer JA, Ergul A, Hess DC. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke. 2010;41:2283\u20137.","journal-title":"Stroke"},{"key":"610_CR23","doi-asserted-by":"crossref","first-page":"18315","DOI":"10.1073\/pnas.1416166111","volume":"111","author":"Y Fu","year":"2014","unstructured":"Fu Y, Zhang N, Ren L, Yan Y, Sun N, Li YJ, Han W, Xue R, Liu Q, Hao J, et al. Impact of an immune modulator fingolimod on acute ischemic stroke. Proc Natl Acad Sci U S A. 2014;111:18315\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"610_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.expneurol.2009.03.044","volume":"218","author":"CT Ajmo Jr","year":"2009","unstructured":"Ajmo Jr CT, Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA, Cuevas J, Willing AE, Pennypacker KR. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol. 2009;218:47\u201355.","journal-title":"Exp Neurol"},{"key":"610_CR25","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1161\/STROKEAHA.109.557967","volume":"40","author":"A Hug","year":"2009","unstructured":"Hug A, Dalpke A, Wieczorek N, Giese T, Lorenz A, Auffarth G, Liesz A, Veltkamp R. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke. 2009;40:3226\u201332.","journal-title":"Stroke"},{"key":"610_CR26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2377-11-110","volume":"11","author":"WF Westendorp","year":"2011","unstructured":"Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;11:110.","journal-title":"BMC Neurol"},{"key":"610_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2014.11.018","volume":"348","author":"W Wang","year":"2015","unstructured":"Wang W, Tang L, Li Y, Wang Y. Biochanin A protects against focal cerebral ischemia\/reperfusion in rats via inhibition of p38-mediated inflammatory responses. J Neurol Sci. 2015;348:121\u20135.","journal-title":"J Neurol Sci"},{"key":"610_CR28","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.STR.28.6.1233","volume":"28","author":"FC Barone","year":"1997","unstructured":"Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 1997;28:1233\u201344.","journal-title":"Stroke"},{"key":"610_CR29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00004647-199808000-00003","volume":"18","author":"RP Stroemer","year":"1998","unstructured":"Stroemer RP, Rothwell NJ. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J Cereb Blood Flow Metab. 1998;18:833\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"610_CR30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00004647-199609000-00017","volume":"16","author":"SA Loddick","year":"1996","unstructured":"Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab. 1996;16:932\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"key":"610_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neuropharm.2015.12.002","volume":"103","author":"S Gao","year":"2016","unstructured":"Gao S, Mo J, Chen L, Wang Y, Mao X, Shi Y, Zhang X, Yu R, Zhou X. Astrocyte GGTI-mediated Rac1 prenylation upregulates NF-kappaB expression and promotes neuronal apoptosis following hypoxia\/ischemia. Neuropharmacology. 2016;103:44\u201356.","journal-title":"Neuropharmacology"},{"key":"610_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neulet.2012.11.052","volume":"534","author":"P Zhang","year":"2013","unstructured":"Zhang P, Liu X, Zhu Y, Chen S, Zhou D, Wang Y. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-kappaB activation and cytokine production of glial cells. Neurosci Lett. 2013;534:123\u20137.","journal-title":"Neurosci Lett"},{"key":"610_CR33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.1999","volume":"15","author":"T Shichita","year":"2009","unstructured":"Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15:946\u201350.","journal-title":"Nat Med"},{"key":"610_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2006.11.014","volume":"184","author":"Q Wang","year":"2007","unstructured":"Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184:53\u201368.","journal-title":"J Neuroimmunol"},{"key":"610_CR35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.01.079","volume":"1323","author":"XH Ye","year":"2010","unstructured":"Ye XH, Wu Y, Guo PP, Wang J, Yuan SY, Shang Y, Yao SL. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res. 2010;1323:174\u201383.","journal-title":"Brain Res"},{"key":"610_CR36","doi-asserted-by":"crossref","first-page":"e4764","DOI":"10.1371\/journal.pone.0004764","volume":"4","author":"A Popp","year":"2009","unstructured":"Popp A, Jaenisch N, Witte OW, Frahm C. Identification of ischemic regions in a rat model of stroke. PLoS One. 2009;4:e4764.","journal-title":"PLoS One"},{"key":"610_CR37","doi-asserted-by":"crossref","first-page":"e46731","DOI":"10.1371\/journal.pone.0046731","volume":"7","author":"G Pal","year":"2012","unstructured":"Pal G, Vincze C, Renner E, Wappler EA, Nagy Z, Lovas G, Dobolyi A. Time course, distribution and cell types of induction of transforming growth factor betas following middle cerebral artery occlusion in the rat brain. PLoS One. 2012;7:e46731.","journal-title":"PLoS One"},{"key":"610_CR38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-2094-7-62","volume":"7","author":"KP Doyle","year":"2010","unstructured":"Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS. TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflammation. 2010;7:62.","journal-title":"J Neuroinflammation"},{"key":"610_CR39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1098\/rstb.2006.1891","volume":"361","author":"BP Liu","year":"2006","unstructured":"Liu BP, Cafferty WB, Budel SO, Strittmatter SM. Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci. 2006;361:1593\u2013610.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"610_CR40","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.neuroscience.2008.07.007","volume":"158","author":"DA Ridder","year":"2009","unstructured":"Ridder DA, Schwaninger M. NF-kappaB signaling in cerebral ischemia. Neuroscience. 2009;158:995\u20131006.","journal-title":"Neuroscience"},{"key":"610_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.lfs.2015.01.030","volume":"126","author":"AE El-Sahar","year":"2015","unstructured":"El-Sahar AE, Safar MM, Zaki HF, Attia AS, Ain-Shoka AA. Sitagliptin attenuates transient cerebral ischemia\/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway. Life Sci. 2015;126:81\u20136.","journal-title":"Life Sci"},{"key":"610_CR42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-11-112","volume":"11","author":"LL Kong","year":"2014","unstructured":"Kong LL, Wang ZY, Han N, Zhuang XM, Wang ZZ, Li H, Chen NH. Neutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats. J Neuroinflammation. 2014;11:112.","journal-title":"J Neuroinflammation"},{"key":"610_CR43","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20021098","volume":"198","author":"K Prass","year":"2003","unstructured":"Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198:725\u201336.","journal-title":"J Exp Med"},{"key":"610_CR44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000210093","volume":"27","author":"FH Vermeij","year":"2009","unstructured":"Vermeij FH, op Reimer WJ S, de Man P, van Oostenbrugge RJ, Franke CL, de Jong G, de Kort PL, Dippel DW. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis. 2009;27:465\u201371.","journal-title":"Cerebrovasc Dis"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0610-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:16:56Z","timestamp":1498306616000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-016-0610-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0610-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]},"article-number":"147"}}